Nuclear Imaging

Navidea, SBIR grant, NCI, NIH, Kaposi's sarcoma, Tc99m tilmanocept, SPECT

Image courtesy of Navidea Biopharmaceuticals Inc.

News | Radiopharmaceuticals and Tracers | September 03, 2015
Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business Innovation Research (...
NorthStar Medical Radioisotopes, approval, routine production, Molybdenum-99, Mo-99, University of Missouri Research Reactor, MURR
News | Radiopharmaceuticals and Tracers | August 31, 2015
NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 (Mo-99) at the...
News | Prostate Cancer | August 21, 2015
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguis
The ITM Group, in-licensing, DOTA-Zoledronate, theranostic agent, bone metastases, PET imaging
News | Radiopharmaceuticals and Tracers | August 20, 2015
The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a next-generation...
Lymphoseek, Navidea, injection site pain, study, breast cancer patients, tracer
News | Radiopharmaceuticals and Tracers | August 20, 2015
August 20, 2015 — Navidea Biopharmaceuticals announced publication of the results from an investigator-initiated, com
IBA Molecular North America, IBAM NA, acquisition, Illinois Health and Science, IBA S.A.
News | Radiopharmaceuticals and Tracers | August 10, 2015
IBA (Ion Beam Applications S.A.) announced the completion of the divestiture of IBA Molecular North America Inc. (IBAM...
Alzheimer's Association, IDEAS Study, website, participation, brain PET scan
News | Neuro Imaging | August 05, 2015
August 5, 2015 — The Alzheimer’s Association announced the launch of a new website for the upcoming Imaging Dementia
biomarkers, Alzheimer's disease, AD, MRI, PET, University of Kentucky, Sanders-Brown Center on Aging
News | Neuro Imaging | July 31, 2015
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are on the hunt for biomarkers that might...
Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers | July 30, 2015
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept...
Videos | Radiation Oncology | July 28, 2015
American Association of Physicists in Medicine (AAPM) President John Boone, Ph.D., discusses the impact of imaging in
Blue Earth Diagnostics, fluciclovine, 18F, orphan drug designation, PET
News | Molecular Imaging | July 09, 2015
Blue Earth Diagnostics Ltd (BED) announced it has received both U.S. Food and Drug Administration (FDA) and European...
SPECT, traumatic brain injury, TBI, post-traumatic stress disorder, PTSD
News | Molecular Imaging | July 08, 2015
After comparing more than 20,000 brain scans, researchers have identified differences between traumatic brain injury (...
Medraysintell, nuclear medicine, World Market Report, radiopharmaceuticals
News | Molecular Imaging | July 06, 2015
Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015, in late June,...
SNMMI, 2015 annual meeting, nuclear medicine, molecular imaging, Baltimore
Feature | Molecular Imaging | June 29, 2015
More than 5,000 physicians, technologists, scientists and exhibitors gathered at the Society of Nuclear Medicine and...
nuclear medicine diagnostic market, North America, PET, SPECT, Mordor
News | Molecular Imaging | June 29, 2015
The Global Nuclear Medicine Diagnostics Market report from Mordor Intelligence revealed that North America accounts for...
Navidea, Manocept, CD206 receptor, rheumatoid arthritis
News | Molecular Imaging | June 26, 2015
Navidea Biopharmaceuticals announced that results from several pre-clinical Manocept studies in rheumatoid arthritis (...
Siemens, MES contract, William Osler Health System, Ontario, Canada
News | Molecular Imaging | June 26, 2015
Canadian hospital William Osler Health System (Osler), based in Ontario, has awarded Siemens Healthcare a Managed...
Siemens, PETNET Solutions, prostate cancer, PET/CT imaging, tracer, New York
News | Molecular Imaging | June 24, 2015
Siemens' PETNET Solutions, a wholly owned subsidiary of Siemens Healthcare, announced it will provide clinical...
News | Molecular Imaging | June 12, 2015
A first-in-human study shows how a powerful new drug finds and attaches itself to the ovarian and prostate cancer cells...
PET, neuroinflammation, C-11 PBR28, dementia, SNMMI 2015
News | June 12, 2015
Neuroinflammation caused by a reactive immune system could be tripping off the neurodegeneration seen in certain...
Overlay Init